Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients. (RASP-HF)

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Heart Failure

Treatments: Other: heart-failure related pharmaceutical intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT02149940

S55301

Details and patient eligibility

About

Heart failure therapies (e.g. beta blockers) have been successful in decreasing mortality rates, as well as diminishing hospitalizations. Also, pharmacist collaboration has been shown to have a beneficial impact on heart failure related outcomes. Regardless, a high residual event rate is to be noted.

In our pilot study, we wished to document whether a clinical pharmacist could still play a role in the heart failure management of an elderly inpatient heart failure population.

Enrollment: 29 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 75 years or older
• diagnosis of previous or new heart failure based on signs and symptoms as defined by the 'European Society of Cardiology guidelines on acute and chronic heart failure'
• diagnosis had to be confirmed by a recent echocardiogram

Exclusion criteria

• not Dutch speaking
• treatment restrictions had been applied on admission

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

29 participants in 1 patient group

clinical pharmacy intervention

Experimental group

Treatment:

Other: heart-failure related pharmaceutical intervention